000 01483 a2200421 4500
005 20250516163728.0
264 0 _c20141009
008 201410s 0 0 eng d
022 _a1778-7254
024 7 _a10.1016/j.jbspin.2013.07.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoberts, Rebecca L
245 0 0 _aFrequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone.
_h[electronic resource]
260 _bJoint bone spine
_cMar 2014
300 _a160-3 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAryl Hydrocarbon Hydroxylases
_xgenetics
650 0 4 _aBenzbromarone
_xtherapeutic use
650 0 4 _aCytochrome P-450 CYP2C9
650 0 4 _aGout
_xdrug therapy
650 0 4 _aGout Suppressants
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNew Zealand
_xethnology
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aPolynesia
_xethnology
650 0 4 _aWhite People
700 1 _aWallace, Mary C
700 1 _aWright, Daniel F B
700 1 _aCadzow, Murray
700 1 _aDalbeth, Nicola
700 1 _aJones, Peter B
700 1 _aStamp, Lisa K
700 1 _aHarrison, Andrew A
700 1 _aBlack, Michael A
700 1 _aMerriman, Tony R
773 0 _tJoint bone spine
_gvol. 81
_gno. 2
_gp. 160-3
856 4 0 _uhttps://doi.org/10.1016/j.jbspin.2013.07.006
_zAvailable from publisher's website
999 _c22992186
_d22992186